CRT 2026
Coronary
Lorenzo Azzalini, MD, PhD, MSc
Interventional Cardiologist
University of Washington
Seattle, Washington, United States
Disclosure(s): Dr. Azzalini received consulting fees from Teleflex, Abiomed, GE Healthcare, Reflow Medical, Shockwave Medical, Abbott, Boston Scientific, XyloCor Therapeutics, HeartFlow, and Cardiovascular Systems, Inc.; and owns equity in Reflow Medical.: Consulting Fees (e.g., advisory boards) (Ongoing)
Carlo Di Mario, MD
Professor
University of Florence
Florence, Toscana, Italy
Disclosure(s): Amgen: Grant/Research Support (Terminated, July 1, 2024); BSC: Grant/Research Support (Ongoing); Novo Nordisk: Grant/Research Support (Ongoing)
Allison B. Hall, MD, FRCPC
Interventional Cardiologist, Clinical Assistant Professor of Medicine
NL Health Services/Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada
Disclosure information not submitted.